ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Perspective Therapeutics (CATX)
Perspective Therapeutics stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · NYSE
$1.19▼ -1.65%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
40%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Perspective Therapeutics in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Perspective Therapeutics
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Perspective Therapeutics a 40% chance of finishing higher a month from now (21 trading sessions) than today: somewhat worse than a coin flip.
In half of the simulated outcomes the price ends between $0.80 and $1.42; in 9 out of 10, between $0.49 and $2.35. Estimated annual volatility is 185%.
Price, last 12 months (weekly close)
Key numbers
- 52-week high
- $6.16
- 52-week low
- $1.06
- Revenue (12 months)
- $0.4M
- Return on equity
- -39.6%
- Free cash flow (12 months)
- $-69.4M
- Beta
- 1.80
What this means
ATLAS does not publish a fair value for CATX right now, but it does show its odds of rising: somewhat worse than a coin flip.
Over the last 52 weeks CATX has traded between $1.06 and $6.16. Today it is 80.7% below that high and 12% above its low.
Its beta is 1.80: it tends to move more than the market, both up and down.
About the company
Perspective Therapeutics Inc. is a radiopharmaceutical company focused on developing and commercializing precision targeted alpha therapies for cancer.
Want to see everything about Perspective Therapeutics?
Get started →Plans from €3.99 a month.
Frequently asked questions
What does Perspective Therapeutics do?
Perspective Therapeutics Inc. is a radiopharmaceutical company focused on developing and commercializing precision targeted alpha therapies for cancer.
What is the chance CATX goes up next month?
40%: somewhat worse than a coin flip. In half of the simulated outcomes, CATX ends the month between $0.80 and $1.42.
How volatile is CATX?
ATLAS estimates annual volatility at 185%. In a typical month, half of the outcomes end between $0.80 and $1.42.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer